Walden Group Healthcare M&A Blog

The Walden Group Releases Q1 2023 Strategic Healthcare M&A Report

5/02/2023
The Walden Group is pleased to provide access to its Q1 2023 Strategic Healthcare M&A Report, which includes:  Q1 2023 Market Overview Noteworthy M&A Deals By Sector Top Deals > $100m in Transaction Value Announced or Closed in Q1 2023 Performance of Leading Healthcare Companies Analysis...
Read More
Werfen Group Buys Immucor for $2b

3/29/2023
Spain-based manufacturer and distributor of diagnostic instruments Werfen has acquired Immucor, a manufacturer of transfusion and transplant diagnostic devices. The acquisition adds platelet detection, diagnostic analyzers, blood monitoring and molecular testing products that help match patients and donors. Deal terms -- $2b. Keywords:...
Read More
The Walden Group Releases 2022 Year-End Strategic Healthcare M&A Report

3/10/2023
The Walden Group is pleased to provide access to its Q4 2022 Strategic Healthcare M&A Report, which includes:  Recent Divestitures and Spin-Offs Diagnostic and Medical Device Deals with Valuations over $100m Noteworthy M&A Deals By Sector Top Deals > $100m in Transaction Value Announced or Closed in 2022 ...
Read More
Shockwave Medical to Acquire Neovasc for $100m

2/7/2023
Shockwave Medical, a $237m developer of technologies treating calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve disease, is acquiring Neovasc, a $2.5m Canada-based developer of transcatheter devices treating refractory angina and mitral valve disease. Deal terms – $100m upfront plus $47m in milestones...
Read More
Zimmer Biomet Acquires Embody for $150m

1/9/2023
Zimmer Biomet Holdings, Inc., a $8.0b maker of orthopedic reconstructive products is acquiring Embody, Inc., a developer of collagen implants for repairing tendons, ligaments and torn rotator cuffs. The acquisition builds Zimmer Biomet’s sports medicine offerings after it spun-off its dental and spine operations into Zimvie, a separate,...
Read More